Study of SGR-3515 In Participants With Advanced Solid Tumors.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Margaret Dugan, MD
CMO/Study Physician
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Stephanie Lheureux, MDRecruiting
- Yale University, Yale Cancer Center
New Haven, Connecticut, United States
Patricia LoRusso, DORecruiting - Northwestern University
Chicago, Illinois, United States
Pedro de Viveiros, MDRecruiting - University of Michigan
Ann Arbor, Michigan, United States
Jean Siedel, DORecruiting - Karmanos Cancer Institute
Detroit, Michigan, United States
Ira Winer, MDRecruiting - Icahn School of Medicine at Mount Sinai
New York, New York, United States
Deborah Doroshow, MDRecruiting - Levine Cancer Institute
Charlotte, North Carolina, United States
Robert W Naumann, MDRecruiting - University of Cincinnati Medical Center
Cincinnati, Ohio, United States
Amanda Jackson, MDRecruiting - Ohio State University
Columbus, Ohio, United States
John Hays, MDRecruiting - Stephenson Cancer Center
Oklahoma City, Oklahoma, United States
Kathleen N Moore, MDRecruiting - Sarah Cannon Research Institute
Nashville, Tennessee, United States
Vivek Subbiah, MDRecruiting - Vanderbilt-Ingram Cancer Center/henry-Joyce Cancer Clinic
Nashville, Tennessee, United States
Michael K Gibson, MDRecruiting - University of Texas Southwestern
Dallas, Texas, United States
David Miller, MDRecruiting - Next Virginia
Fairfax, Virginia, United States
Mohamad A Salkeni, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Jun 2024
- Primary completion
- 31 Oct 2026
- Completion
- 31 Dec 2026
- Last update posted
- 1 Aug 2025
- Registered enrollment
- 52
- Registry id
- NCT06463340
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.